10x Genomics Denmark ApS: Financial statements 2020
CVR: 40243224
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
10x Genomics Denmark ApS (CVR 40243224) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,602,244 and a net result of DKK -2,027,263 compared with DKK 245,383 the year before. Equity in the 2020 report amounted to DKK -1,401,879. The company had 2 employees in the financial year.
- Gross Profit
- DKK -1,602,244
- Profit/Loss
- DKK -2,027,263
- Equity
- DKK -1,401,879
- Total Assets
- DKK 2,479,615
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -1.6 mio. | -2 mio. | -1.4 mio. | 2 |
| 2019 | - | 552 t. | 245 t. | 625 t. | - |
Official annual report
How creditworthy is 10x Genomics Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
10x Genomics Denmark ApS has published its annual report for 2019. Gross profit came to DKK 552,190, and the net result was DKK 245,383.
About 10x Genomics Denmark ApS
10x Genomics Denmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Tetramer Shop ApS. The management consists of Adam Samuel Taich and James Sears Bryant. The company is owned by 10x Genomics, Inc.. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,442,436 and a net result of DKK 154,956 compared with DKK 183,445 the year before. Equity in the 2025 report amounted to DKK 973,740.